Reduction in sumoylation-dependent S100A4 nuclear import in cholangiocarcinoma by low dose paclitaxel halts tumor invasiveness and hematogenoous metastasization by down-modulating Rho-A and Cdc42 activities. (15th February 2015) - Spagnuolo, G.; Cadamuro, M.; Sambado, L.; Indraccolo, S.; Nardo, G.; Rosato, A.; Novelli, E.; Spirli, C.; Strazzabosco, M.; Fabris, L.